Lexeo Therapeutics, Inc. (LXEO)
9.85
+0.11
(+1.13%)
USD |
NASDAQ |
Dec 31, 13:20
Lexeo Therapeutics Market Cap: 326.94M for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.537B |
| Anixa Biosciences, Inc. | 103.69M |
| GT Biopharma, Inc. | 8.333M |
| Moleculin Biotech, Inc. | 6.872M |
| Phathom Pharmaceuticals, Inc. | 1.189B |
Market Cap Related Metrics
| Price to Book Value | 2.706 |
| Price | 9.85 |
| Earnings Yield | -27.43% |